Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Annals of Hematology
Published in: Annals of Hematology 9/2005

01-09-2005 | Letter to the Editor

Durable complete remission after chemotherapy and rituximab in a case of Waldenström’s macroglobulinemia with pleuropulmonary involvement

Authors: Silvana Capalbo, Michelina Dargenio, Mario Delia, Antonella Chiefa, Daniela Diomede, Anna Napoli, Rosalia Ricco, Vincenzo Liso

Published in: Annals of Hematology | Issue 9/2005

Login to get access

Excerpt

Dear Editor, …
Literature
1.
Fadil A, Taylor DE (1998) The lung and Waldenström’s macroglobulinemia. South Med J 91:681–685PubMed
2.
Kyrtsonis MC, Angelopoulou MK, Kontopidou FN, Siakantaris MP, Dimopoulou MN, Mitropoulos F, Kalovidouris A, Vaiopoulos GA, Pangalis G (2001) Primary lung involvement in Waldenström’s macroglobulinemia. Acta Haematol 105:92–96CrossRefPubMed
3.
Dimopoulos MA, Kyle RA, Anagnostopoulos A, Treon SP (2005) Diagnosis and management of Waldenström’s macroglobulinemia. J Clin Oncol 23:1564–1577CrossRefPubMed
4.
Treon SP, Branagan AR, Hunter Z, Santos D, Tournhilac O, Anderson KC (2004) Paradoxical increases in serum IgM levels and viscosity levels following rituximab therapy in Waldenström’s macroglobulinemia. Ann Oncol 15:1481–1483CrossRefPubMed
5.
Treon SP, Hunter Z, Branagan AR (2005) CHOP plus rituximab in Waldenström’s macroglobulinemia. Clin Lymphoma 5:273–277PubMed
Metadata
Title
Durable complete remission after chemotherapy and rituximab in a case of Waldenström’s macroglobulinemia with pleuropulmonary involvement
Authors
Silvana Capalbo
Michelina Dargenio
Mario Delia
Antonella Chiefa
Daniela Diomede
Anna Napoli
Rosalia Ricco
Vincenzo Liso
Publication date
01-09-2005
Publisher
Springer-Verlag
Published in
Annals of Hematology / Issue 9/2005
Print ISSN: 0939-5555
Electronic ISSN: 1432-0584
DOI
https://doi.org/10.1007/s00277-005-1061-1

Other articles of this Issue 9/2005

Annals of Hematology 9/2005 Go to the issue

Original Article

Thalidomide in combination with dexamethasone for pretreated patients with multiple myeloma: serum level of soluble interleukin-2 receptor as a predictive factor for response rate and for survival

Original Article

A multicenter, open, noncomparative, phase II study of the combination of cladribine (2-chlorodeoxyadenosine), cytarabine, granulocyte colony-stimulating factor and mitoxantrone as induction therapy in refractory acute myeloid leukemia: a report of the Polish Adult Leukemia Group

Original Article

Blood mononuclear cells and platelets have abnormal fatty acid composition in homozygous sickle cell disease

Original Article

A deletion of 11 bp (CD 131–134) in exon 3 of the β-globin gene produces the phenotype of inclusion body β-thalassemia

Letter to the Editor

Myelodysplastic syndrome of donor origin subsequent to successful treatment of myeloid/NK-cell precursor leukaemia with allogeneic PBSCT: two very rare conditions in one patient

Original Article

Clinical usefulness of free light chain concentration as a tumor marker in multiple myeloma
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits